Smith SM, Zhang S, Sundaram V, Roth M, Andolina JR, Schapira L, Sakamoto KM, Kolb EA, Hijiya N, Chaudhury S. Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. Pediatr Hematol Oncol. 2022 Aug;39(5):453-467. doi: 10.1080/08880018.2021.2017085. Epub 2021 Dec 17. PMID: 34918996.
(AUTHOR DEPOSITED)
